Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrante

Showing results (241-250 of 350) with videos related to

Pageof 35
Sort By:
Journal of Crohn'S & Colitis|September 27, 2022
What are the Unmet Needs and Most Relevant Treatment Outcomes According to Patients with Inflammatory Bowel Disease? A Qualitative Patient Preference StudyElise Schoefs, Séverine Vermeire, Marc Ferrante, et al.
European Journal of Gastroenterology & Hepatology|January 20, 2022
Assessing aCCess to Investigations in Inflammatory Bowel Disease (ACCID): results from an international surveyNik S Ding, Tanya Lee, Dominik Bettenworth, et al.
Journal of Crohn'S & Colitis|August 31, 2016
A Simplified Geboes Score for Ulcerative ColitisAranzazu Jauregui-Amezaga, Auke Geerits, Yannick Das, et al.
Immunology|October 9, 2012
Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximabClémentine Perrier, Ingrid Arijs, Dominiek Staelens, et al.
Gastro Hep Advances|August 12, 2024
Shorter Crohn's Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 StudiesLaurent Peyrin-Biroulet, Jean-Frederic Colombel, Edouard Louis, et al.
Journal of Crohn'S & Colitis|July 29, 2016
Submucosal Plexitis as a Predictive Factor for Postoperative Endoscopic Recurrence in Patients with Crohn's Disease Undergoing a Resection with Ileocolonic Anastomosis: Results from a Prospective Single-centre StudyBart Lemmens, Anthony de Buck van Overstraeten, Ingrid Arijs, et al.
Gut|November 2, 2016
Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UCIngrid Arijs, Gert De Hertogh, Bart Lemmens, et al.
European Journal of Pediatrics|August 2, 2008
Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel diseaseMirjam Bueno de Mesquita, Marc Ferrante, Liesbet Henckaerts, et al.
The New England Journal of Medicine|March 29, 2023
Vedolizumab for the Treatment of Chronic PouchitisSimon Travis, Mark S Silverberg, Silvio Danese, et al.
Clinical and Translational Gastroenterology|May 1, 2024
Fibrostricturing Crohn's Disease Is Marked by an Increase in Active Eosinophils in the Deeper LayersInge Jacobs, Bo-Jun Ke, Matthias Ceulemans, et al.
Pageof 35

Showing results (241-250 of 350) with videos related to

Sort By:
Pageof 35
Journal of Crohn'S & Colitis|September 27, 2022
What are the Unmet Needs and Most Relevant Treatment Outcomes According to Patients with Inflammatory Bowel Disease? A Qualitative Patient Preference StudyElise Schoefs, Séverine Vermeire, Marc Ferrante, et al.
European Journal of Gastroenterology & Hepatology|January 20, 2022
Assessing aCCess to Investigations in Inflammatory Bowel Disease (ACCID): results from an international surveyNik S Ding, Tanya Lee, Dominik Bettenworth, et al.
Journal of Crohn'S & Colitis|August 31, 2016
A Simplified Geboes Score for Ulcerative ColitisAranzazu Jauregui-Amezaga, Auke Geerits, Yannick Das, et al.
Immunology|October 9, 2012
Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximabClémentine Perrier, Ingrid Arijs, Dominiek Staelens, et al.
Gastro Hep Advances|August 12, 2024
Shorter Crohn's Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 StudiesLaurent Peyrin-Biroulet, Jean-Frederic Colombel, Edouard Louis, et al.
Journal of Crohn'S & Colitis|July 29, 2016
Submucosal Plexitis as a Predictive Factor for Postoperative Endoscopic Recurrence in Patients with Crohn's Disease Undergoing a Resection with Ileocolonic Anastomosis: Results from a Prospective Single-centre StudyBart Lemmens, Anthony de Buck van Overstraeten, Ingrid Arijs, et al.
Gut|November 2, 2016
Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UCIngrid Arijs, Gert De Hertogh, Bart Lemmens, et al.
European Journal of Pediatrics|August 2, 2008
Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel diseaseMirjam Bueno de Mesquita, Marc Ferrante, Liesbet Henckaerts, et al.
The New England Journal of Medicine|March 29, 2023
Vedolizumab for the Treatment of Chronic PouchitisSimon Travis, Mark S Silverberg, Silvio Danese, et al.
Clinical and Translational Gastroenterology|May 1, 2024
Fibrostricturing Crohn's Disease Is Marked by an Increase in Active Eosinophils in the Deeper LayersInge Jacobs, Bo-Jun Ke, Matthias Ceulemans, et al.
Pageof 35